ATE200734T1 - Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos - Google Patents

Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Info

Publication number
ATE200734T1
ATE200734T1 AT93117796T AT93117796T ATE200734T1 AT E200734 T1 ATE200734 T1 AT E200734T1 AT 93117796 T AT93117796 T AT 93117796T AT 93117796 T AT93117796 T AT 93117796T AT E200734 T1 ATE200734 T1 AT E200734T1
Authority
AT
Austria
Prior art keywords
composition
risk
hypotension
patient
reducing
Prior art date
Application number
AT93117796T
Other languages
English (en)
Inventor
David A Mark
Gary Pace
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE200734T1 publication Critical patent/ATE200734T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93117796T 1992-11-05 1993-11-03 Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos ATE200734T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/971,949 US5356873A (en) 1992-11-05 1992-11-05 Method for providing nutritional requirements to patients having a chronic inflammation reaction

Publications (1)

Publication Number Publication Date
ATE200734T1 true ATE200734T1 (de) 2001-05-15

Family

ID=25518983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93117796T ATE200734T1 (de) 1992-11-05 1993-11-03 Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Country Status (11)

Country Link
US (1) US5356873A (de)
EP (1) EP0612522B1 (de)
JP (1) JPH0797332A (de)
AT (1) ATE200734T1 (de)
AU (1) AU5040593A (de)
CA (1) CA2109392A1 (de)
DE (1) DE69330177T2 (de)
DK (1) DK0612522T3 (de)
ES (1) ES2157208T3 (de)
GR (1) GR3036272T3 (de)
PT (1) PT612522E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
EP1178821B1 (de) * 1999-04-29 2005-12-14 Novo Nordisk A/S Verwendung von anti-hbp antikörper zur inhibierung der freisetzung von bradykinin
US6833350B2 (en) 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
NZ552706A (en) * 2004-07-19 2011-01-28 Nutricia Nv Use of aspartate for regulating glucose levels in blood
JP2009533342A (ja) * 2006-04-04 2009-09-17 ネステク ソシエテ アノニム シトルリンを使用する治療
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20200033A1 (ar) 2017-08-14 2020-02-13 Axcella Health Inc تركيبات حمض أميني لمعالجة مرض كبدي
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5158883A (en) * 1989-09-13 1992-10-27 Cornell Research Foundation, Inc. Method of using aminoarginine to block nitric oxide formation in vitro
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
EP0663826B1 (de) * 1991-09-27 1998-12-23 Board Of Regents The University Of Texas System Parenteral anzuwendende Aminosäuren enthaltende Zubereitungen zur Bekämpfung von Hypotension und verwandten Pathologien

Also Published As

Publication number Publication date
US5356873A (en) 1994-10-18
PT612522E (pt) 2001-08-30
EP0612522A1 (de) 1994-08-31
DE69330177T2 (de) 2001-09-06
DK0612522T3 (da) 2001-08-13
GR3036272T3 (en) 2001-10-31
DE69330177D1 (de) 2001-05-31
ES2157208T3 (es) 2001-08-16
JPH0797332A (ja) 1995-04-11
CA2109392A1 (en) 1994-05-06
AU5040593A (en) 1994-05-19
EP0612522B1 (de) 2001-04-25

Similar Documents

Publication Publication Date Title
GB8524276D0 (en) Pharmaceutical & dietary compositions
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
AU5763094A (en) Composition and method for treating patients with hepatic disease
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
IL110643A0 (en) Amidine derivatives, their preparation and pharmaceutical compositions containing them
EP0690722A4 (de) Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
ES2175023T3 (es) Composiciones nutricionales en varias formas.
TW336171B (en) Pharmaceutical composition for use in the treatment of vulvar dystrophy and/or vaginal dryness
ATE200734T1 (de) Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos
DE3680271D1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
EP0502925A4 (en) Method and composition for treating inflammatory bowel disorders
EP0506658A4 (en) Compositions and method for treating painful, inflammatory or allergic disorders
EP0934748A3 (de) Von Willenbrand Faktor (vWF) enthaltende Zubereitung, verfahren zür Herstellung von vWF enthaltenden Zubereitungen und deren Verwendung
ATE268587T1 (de) Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
EP0502313A3 (en) Method for insuring adequate intracellular glutathione in tissue
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
DE69002743D1 (de) Verfahren zur verbesserung der ventilation waehrend des schlafes und behandlung von ventilationsabnormalitaeten, die mit dem schlaf verbunden sind.
TW232014B (de)
TW217382B (de)
ATE302611T1 (de) Humanes wachstumshormon als hilfe gegen unterkühlung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee